Cytek Biosciences, Inc. (CTKB) Builds Spectral TechnologyCytek Biosciences, Inc.NASDAQ:CTKBtraderspro_chartsCytek Biosciences, Inc. (CTKB) develops advanced cell analysis tools used by researchers in life sciences and drug development. Its Full Spectrum Profiling technology powers systems including Aurora, Aurora Evo, Borealis, and Northern Lights. Growth comes from wider adoption of spectral flow cytometry, new instruments, expanding reagents and software, and Cytek Cloud’s growing digital ecosystem. On the chart, CTKB printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.